Solid-phase medium surface double-end amplification sequencing method

Through the double-end amplification sequencing method on the surface of solid phase media, the double-end sequencing steps are simplified by shear sites, and the problems of complex and incompatible double-end sequencing steps in the existing technology are solved, achieving efficient and accurate double-end sequencing steps Sequencing compatible with fluorescence generation sequencing.

CN119082279APending Publication Date: 2024-12-06CYGNUS BIOSCI BEIJING CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411466718.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2022-01-28
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

In the existing high-throughput sequencing technology, double-ended sequencing requires multiple amplifications and library construction, resulting in complex steps and incompatible fluorescence sequencing. The existing double-ended amplification methods are complex and incompatible.

Method used

Using the double-ended amplification sequencing method on the surface of solid phase media, double-strand generation and sequencing are performed by fixing the amplification oligonucleotides on the solid phase media, using shear sites to reduce the amplification steps and achieve double-ended sequencing compatible fluorescence generation. Sequencing.

Benefits of technology

The two-ended sequencing steps are simplified, the sequencing efficiency and accuracy are improved, and the compatibility is more suitable for platforms such as Illumina and Ion Torrent.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082279A_ABST
    Figure CN119082279A_ABST
Patent Text Reader

Abstract

The invention relates to a method for double-end amplification sequencing on the surface of a solid-phase medium, which only needs to perform an amplification reaction once, after a first chain is subjected to a sequencing reaction, a generated sequencing chain is fixed on the surface of the solid-phase medium to serve as a second chain to be sequenced, so that double-end sequencing is realized, a two-chain generation step required by double-end sequencing is reduced, and time is saved; the double-end amplification sequencing method disclosed by the invention is particularly suitable for fluorescence generation sequencing, is also suitable for various other sequencing technologies, and is higher in compatibility.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] This application is a divisional application of an application with an application date of January 28, 2022, application number 202210109568.1, and invention name “A method for double-end amplification sequencing on a solid phase medium surface”. Technical Field

[0002] The invention relates to a method for double-end amplification sequencing on a solid phase medium surface, belonging to the field of gene sequencing. Background Art

[0003] At present, high-throughput sequencing technology is developing rapidly and has become a commonly used analytical method for life research. It has the characteristics of high throughput, fast detection speed, flexibility and versatility, and low cost. This technology requires exponential amplification of the target DNA through amplification, so as to achieve the purpose of simultaneously detecting hundreds of thousands to millions of DNA molecules. Therefore, one sequencing technology corresponds to one amplification method. At present, the simpler one in the field of high-throughput sequencing is single-end sequencing, that is, only one sequencing primer is required, and the sequencing is extended from the 5'-3' direction of the primer during sequencing. The signal can only be read in one direction, and the amplification used is also relatively simple. The target DNA can be amplified once by PCR or other amplification techniques to obtain a large number of samples to be tested. However, the quality of single-end sequencing will decrease as the sequencing proceeds, the sequencing sequence will become less accurate as time goes on, and the read length will be subject to certain restrictions.

[0004] Paired-end sequencing technology refers to adding sequencing primer binding sites to the adapters at both ends when constructing the DNA library to be tested. After the first round of sequencing is completed, the template chain of the first round of sequencing is removed, and the paired-end sequencing module (Paired-EndModule) is used to guide the complementary chain to be regenerated and amplified in situ to reach the template amount used for the second round of sequencing, and the second round of synthetic sequencing of the complementary chain is performed. This sequencing method improves the utilization rate of samples. Only one library construction is required to achieve two sequencings; sequencing data with high accuracy and long read length can be obtained, and insertion and deletion variations that cannot be detected by single-end sequencing data can be detected. At present, companies that can perform double-end sequencing, such as Illumina and BGI, all have double-end amplification methods corresponding to their sequencing technologies, but these methods are either directly incompatible with existing fluorescent sequencing methods or require special and complex library construction processes. Therefore, it is necessary to develop more compatible double-end amplification sequencing methods. Summary of the invention

[0005] The Summary is not intended to limit the scope of the claimed subject matter. Other features, details, utilities, and advantages of the claimed subject matter will appear from the detailed description of aspects including those disclosed in the accompanying drawings and the appended claims.

[0006] The present invention discloses a method for double-end amplification sequencing on a solid phase medium surface, which is characterized by comprising:

[0007] (1) providing at least two amplification oligonucleotides fixed on the surface of a solid phase medium, that is, providing at least a first amplification oligonucleotide and a second amplification oligonucleotide; the at least two amplification oligonucleotides include a first amplification oligonucleotide having a cleavage site and a second amplification oligonucleotide having a cleavage site, and the two cleavage sites are different; the surface of the solid phase medium is modified with a chemical group;

[0008] (2) providing a single-stranded template polynucleotide, and loading the single-stranded template polynucleotide onto the surface of a solid phase medium by hybridization with the first amplification oligonucleotide; the single-stranded template polynucleotide contains common linker sequences at both ends, namely, linker sequence 1 and linker sequence 2, wherein linker sequence 1 and at least a portion of the sequence of the first amplification oligonucleotide are complementary; and linker sequence 2 and at least a portion of the sequence of the second amplification oligonucleotide are identical;

[0009] (3) initial extension: extending the first amplification oligonucleotide to generate an extension product complementary to the single-stranded template polynucleotide;

[0010] (4) amplification: providing amplification reactants, performing amplification on the surface of the medium, and generating a plurality of double-stranded polynucleotides fixed on the surface of the medium, wherein the double-stranded polynucleotides include a first strand and a second strand;

[0011] (5) Shearing: by acting on the first amplification oligonucleotide having a shearing site, the first amplification oligonucleotide is interrupted at the shearing site, and the second strand in the double-stranded polynucleotide is selectively removed;

[0012] (6) Capping: adding a capping agent to block the 3' end of the polynucleotide chain or oligonucleotide on the surface of the medium;

[0013] (7) First-strand sequencing: hybridization of the first sequencing primer and sequencing;

[0014] A. The 5' end of the first sequencing primer is modified with a specific group; the group is selected from one or more of amino, carboxyl, epoxy, hydroxyl, aldehyde, azido, alkynyl, cycloalkynyl, maleimide, succinimide or thiol; the specific group can react with the chemical group modified on the surface of the solid phase medium;

[0015] B. After the first-strand sequencing reaction is completed, the single-stranded polynucleotide extended from the first sequencing primer is reacted with the chemical group on the surface of the solid phase medium through the specific group at the 5' end of the first sequencing primer without unwinding, and is fixed to the surface of the solid phase medium. The single-stranded polynucleotide is the second strand on the surface of the solid phase medium that is complementary to the first strand;

[0016] (8) Shearing: by acting on the second amplification oligonucleotide, breaking the second amplification oligonucleotide at the shearing site, and selectively removing the first strand of the double-stranded polynucleotide;

[0017] (9) Capping: adding a capping agent to block the 3' end of the polynucleotide chain or oligonucleotide on the surface of the medium;

[0018] (10) Second strand sequencing: hybridize the second sequencing primer and sequence.

[0019] According to a preferred embodiment, the solid phase medium includes an inert substrate or matrix and a media material, wherein the media material is directly attached to the amplified oligonucleotide and is connected to the inert substrate or matrix by covalent or non-covalent forces; the media material includes but is not limited to a hydrogel layer, hydrogel microspheres, and magnetic microspheres; the material of the inert substrate or matrix includes but is not limited to glass, silicon, silicon dioxide, optical fiber or optical fiber bundle, resin, ceramic, metal, nitrocellulose, polyethylene, polystyrene, copolymers of styrene and other materials, polypropylene, acrylic acid, polybutylene or polyurethane.

[0020] According to a preferred embodiment, the surface of the solid phase medium has discretely distributed concave structures, which are micro-reaction chambers for reactions to occur, and the shapes may be cylindrical, truncated cone, groove, quasi-truncated cone or quasi-hexagonal column structure, or a combination thereof.

[0021] According to a preferred embodiment, the chemical groups modified on the surface of the solid phase medium include amino, carboxyl, epoxy, hydroxyl, aldehyde, azido, alkynyl, cycloalkynyl, maleimide, succinimide or thiol, etc.; the at least two amplification oligonucleotides are fixed on the surface of the solid phase medium by reacting with the chemical groups.

[0022] According to a preferred embodiment, the cleavage site allows enzymatic cleavage, chemical cleavage or photochemical cleavage.

[0023] According to a preferred embodiment, wherein said cleavage comprises contacting said solid phase medium with a composition comprising at least one enzyme to generate an abasic site at said cleavage site, wherein said cleavage occurs at said cleavage site.

[0024] According to a preferred embodiment, after the cleavage reaction is completed, an extendable 3' end needs to be generated, that is, if a phosphate group is formed at the 3' end after the cleavage reaction, it is necessary to treat with a phosphate kinase or phosphatase including T4 polynucleotide kinase to remove the phosphate group at the 3' end formed after the cleavage to generate an extendable 3' end.

[0025] According to a preferred embodiment, the amplification is one of loop-mediated isothermal amplification (LAMP), recombinase polymerase amplification (RPA), recombinase-mediated isothermal nucleic acid amplification (RAA), nicking endonuclease isothermal amplification (NEAR), rolling circle amplification (RCA), nucleic acid sequence-dependent amplification (NASBA), helicase-dependent amplification (HDA), strand displacement amplification (SDA) or bridge PCR.

[0026] According to a preferred embodiment, wherein the template polynucleotide comprises a first index and a second index, the method further comprises sequencing the first index and the second index.

[0027] According to the aforementioned optional embodiment, the sequencing is sequencing by synthesis or sequencing by ligation, preferably fluorescence sequencing.

[0028] According to a preferred embodiment, the cleavage site is a site for cleavage with a nicking endonuclease.

[0029] According to a preferred embodiment, the amplification oligonucleotide comprises uracil base, 8-oxoguanine base, deoxyhypoxanthine base or tetrahydrofuran modified base.

[0030] According to a preferred embodiment, the at least one enzyme that generates an abasic site at the cleavage site comprises uracil DNA glycosylase and an endonuclease or endonuclease IV selected from DNA glycosylase-lyase endonuclease VIII or Fpg glycosylase.

[0031] According to a preferred embodiment, the cleavage site is selected from uracil bases, 8-oxoguanine bases, deoxyxanthine bases, tetrahydrofuran-modified bases, ortho-bishydroxy-modified phosphoramidite sites, disulfide groups, azo groups, azide groups, peptide bonds, one or more ribonucleotides, ketals, acetals, diphenylsiloxanes, carbonates or carbamates, etc.

[0032] The present invention also provides a gene sequencing method, characterized in that the nucleic acid molecules to be tested are fragmented, and a template polynucleotide is obtained through library construction, and amplification and sequencing are performed according to any of the methods described above.

[0033] Beneficial Effects

[0034] 1. In the prior art, in order to achieve double-end sequencing (or paired sequencing), it is necessary to perform an amplification or extension reaction after the first chain sequencing is completed to obtain enough second chains for sequencing. The method disclosed in the present invention only requires one amplification reaction. After the first chain is sequenced, the generated sequencing chain is fixed to the surface of the solid phase medium as the second chain to be sequenced, and double-end sequencing can be achieved, which reduces the steps required for double-end sequencing and saves time.

[0035] 2. The double-end amplification sequencing method disclosed in the present invention has stronger compatibility. It not only solves the problem of incompatibility between double-end amplification and fluorescence sequencing in the prior art, but can also be applied to double-end sequencing of libraries built by Illumina and Ion Torrent. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1. Brightness of microspheres and efficiency of second chain generation when hybridizing fluorescent labeled probes after first and second chains are generated in Example 1. Figure 1A The left picture shows the brightness of the microspheres after the first strand is generated and hybridized with the fluorescent labeled probe. Figure 1A The right image shows the brightness of the microspheres when the fluorescently labeled probe is hybridized after the second strand is generated; Figure 1B Generates an efficiency plot for the second chain drawn by MATLAB.

[0037] Figure 2. Brightness of microspheres and efficiency of second chain generation when the fluorescent labeled probe is hybridized after the first and second chains are generated in Example 2. Figure 2A The left picture shows the brightness of the microspheres after the first strand is generated and hybridized with the fluorescent labeled probe. Figure 2A The right image shows the brightness of the microspheres when the fluorescently labeled probe is hybridized after the second strand is generated; Figure 2B Generates an efficiency plot for the second chain drawn by MATLAB.

[0038] Figure 3. Brightness of microspheres and efficiency of second chain generation when the fluorescent labeled probe is hybridized after the first and second chains are generated in Example 3.

[0039] Figure 3A The left picture shows the brightness of the microspheres after the first strand is generated and hybridized with the fluorescent labeled probe. Figure 3A The right image shows the brightness of the microspheres when the fluorescently labeled probe is hybridized after the second strand is generated; Figure 3B Generates an efficiency plot for the second chain drawn by MATLAB.

[0040] Figure 4. Brightness of microspheres and efficiency of second chain generation when the fluorescent labeled probe is hybridized after the first and second chains are generated in Example 4.

[0041] Figure 4A The left picture shows the brightness of the microspheres after the first strand is generated and hybridized with the fluorescent labeled probe. Figure 4A The right image shows the brightness of the microspheres when the fluorescently labeled probe is hybridized after the second strand is generated; Figure 4B Generates an efficiency plot for the second chain drawn by MATLAB. DETAILED DESCRIPTION

[0042] The present invention will be further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention, rather than to limit the present invention. The sizes and shapes of the various parts in the accompanying drawings do not represent the actual proportions, but are only used to illustrate the present invention.

[0043] Unless otherwise defined, all scientific and technical terms used herein have the same meaning as commonly understood by those of ordinary skill in the art. The use of the term "comprising" is not restrictive and should be interpreted as having an open meaning, that is, it should be interpreted synonymously with the phrase "at least comprising".

[0044] The double-end amplification sequencing technology described in this patent achieves compatibility with fluorescence sequencing, and can obtain more and more accurate sequencing data than single-end sequencing.

[0045] Specifically, the present invention discloses a method for double-end amplification sequencing on a solid phase medium surface, characterized in that it comprises:

[0046] (1) providing at least two amplification oligonucleotides immobilized on the surface of a solid phase medium, that is, providing at least a first amplification oligonucleotide and a second amplification oligonucleotide; wherein at least part of the first amplification oligonucleotides contain a cleavage site, and all of the second amplification oligonucleotides contain a cleavage site;

[0047] (2) providing a single-stranded template polynucleotide, and loading the single-stranded template polynucleotide onto the surface of a solid phase medium by hybridization with the first amplification oligonucleotide; the single-stranded template polynucleotide contains common linker sequences at both ends, namely, linker sequence 1 and linker sequence 2, wherein linker sequence 1 and at least a portion of the sequence of the first amplification oligonucleotide are complementary; and linker sequence 2 and at least a portion of the sequence of the second amplification oligonucleotide are identical;

[0048] (3) initial extension: extending the first amplification oligonucleotide to generate an extension product complementary to the single-stranded template polynucleotide; unwinding to obtain a single-stranded polynucleotide on the surface of the medium that is complementary to the template polynucleotide;

[0049] (4) amplification: providing amplification reactants, performing amplification on the surface of the medium, and generating a plurality of double-stranded polynucleotides fixed on the surface of the medium, wherein the double-stranded polynucleotides include a first strand and a second strand;

[0050] (5) Shearing: by acting on the first amplification oligonucleotide having a shearing site, the first amplification oligonucleotide is interrupted at the shearing site, the second strand in the double-stranded polynucleotide is selectively removed, and an extendable 3' end is generated;

[0051] (6) Capping: adding a capping agent to block the 3' end of the polynucleotide chain or oligonucleotide on the surface of the medium;

[0052] (7) First-strand sequencing: hybridization of the first sequencing primer and sequencing;

[0053] (8) Shearing: by acting on the second amplification oligonucleotide, breaking the second amplification oligonucleotide at the shearing site, selectively removing the first strand in the double-stranded polynucleotide, and generating an extendable 3' end;

[0054] (9) Capping: adding a capping agent to block the 3' end of the polynucleotide chain or oligonucleotide on the surface of the medium;

[0055] (10) Second strand sequencing: hybridization of the second sequencing primer and sequencing;

[0056] The surface of the solid phase medium is modified with chemical groups.

[0057] The method of the present invention first fixes at least two amplification oligonucleotides on the surface of the solid phase medium, and the term "fixation" refers to the oligonucleotides being directly or indirectly attached to the solid phase medium via covalent bonds or non-covalent bonds. For example, the amplification oligonucleotides can be attached to the solid phase medium through a specific reaction between their 5' ends and chemical groups modified on the surface of the solid phase medium, and the groups include amino, carboxyl, epoxy, hydroxyl, aldehyde, azido, alkynyl, cycloalkynyl, maleimide, succinimide, sulfhydryl, etc.

[0058] In the present invention, for two or more amplification oligonucleotides, each includes a plurality; a plurality includes 2, 3, 4, 5, 6, 7, 8, 9, 10, 50, 100 or more population members; a plurality may also include 200, 300, 400, 500, 1000, 5000, 10000, 50000, 1x10. 5 , 2x10 5 , 3x10 5 , 4x10 5 , 5x10 5 , 6x10 5 , 7x10 5 , 8x10 5 , 9x10 5 、lx10 6 , 2x10 6 , 3x10 6 , 4x10 6 , 5x10 6 , 6x10 6 , 7x10 6 , 8x10 6 , 9x10 6 or more members, a plurality including all integers between the above exemplary population numbers.

[0059] The term "amplification oligonucleotide" refers to a sequence including an amplification primer, which may be composed entirely of natural or modified nucleotides (e.g., 8-oxoguanine, methylated nucleotides, etc.), and may also include necessary non-nucleotide chemical spacers, including but not limited to units containing disulfide groups or dihydroxyl groups or azo groups or azide groups, etc.

[0060] In the present invention, the term "solid phase medium" refers to any insoluble inert substrate or matrix to which nucleic acid molecules can be attached, including but not limited to glass, silicon, silicon dioxide, optical fiber or optical fiber bundle, resin, ceramic, metal, nitrocellulose, polyethylene, polystyrene, copolymers of styrene and other materials, polypropylene, acrylic acid, polybutylene, polyurethane. The shape of the surface is optional, including, for example, porous, planar or spherical suitable for a particular application. Preferably, the solid phase medium is installed inside the flow cell to allow its interaction with multiple reagent solutions.

[0061] According to a preferred embodiment, the surface of the solid phase medium has a discretely distributed concave structure, which is a micro-reaction chamber where the reaction occurs, and the shape can be cylindrical, truncated cone, groove, quasi-truncated cone, quasi-hexagonal column structure, or a combination thereof. The micro-reaction chamber can be arrayed or non-arrayed. Each micro-reaction chamber is a reaction chamber, and when it is fed back to the sequencing data, it corresponds to a data point. This is a common fact in sequencing reactions.

[0062] In some preferred embodiments, the solid phase medium includes an inert substrate or matrix and a media material, the media material directly attaches the amplified oligonucleotide and is connected to the inert substrate or matrix by covalent or non-covalent forces; the media material includes but is not limited to a hydrogel layer, a hydrogel microsphere, and a magnetic microsphere; the material of the inert substrate or matrix includes but is not limited to glass, silicon, silicon dioxide, optical fiber or optical fiber bundle, resin, ceramic, metal, nitrocellulose, polyethylene, polystyrene, copolymers of styrene and other materials, polypropylene, acrylic acid, polybutylene, and polyurethane. The media material is modified with specific chemical groups and can covalently attach nucleic acid molecules. In particular, the media material can also include magnetic microspheres, which are confined to the surface of the inert substrate or matrix by magnetic force.

[0063] In some preferred embodiments, the medium material is a microsphere, including hydrogel microspheres and magnetic microspheres. The diameter of the microspheres should match the size of the microreaction chamber, that is, the diameter of the microspheres should be smaller than the size of the microreaction chamber and not less than half of the size, so that the microspheres can enter the microreaction chamber and no more than one microsphere can enter a microreaction chamber.

[0064] In some preferred embodiments, the media material of the present invention is a polymer coating, and polymer coatings that can be used to deposit nucleic acids are well known in the art, such as a polyacrylamide hydrogel layer. The hydrogel layer can be covalently attached to the amplification oligonucleotide as an intermediate layer, and the hydrogel layer can also be attached to the inert substrate or matrix by non-covalent action, and the inert substrate or matrix includes but is not limited to glass, silicon wafer, etc.

[0065] In some embodiments, magnetic microspheres are a possible option. Magnetic microspheres can exert force through an external magnetic field and can play a role under certain special conditions.

[0066] In the present invention, the medium material may be hydrogel microspheres. For the preparation method of hydrogel microspheres, reference may be made to patent CN202010087598.8. In particular, the content of the above patent may be incorporated into this patent by reference.

[0067] According to a preferred embodiment, the size of the microspheres is 0.2-5 microns, preferably 0.3-3 microns, and more preferably 0.35-2.5 microns.

[0068] In some preferred embodiments, firstly, a medium material (microsphere) immobilized with three amplification oligonucleotides (including a first amplification oligonucleotide with a cleavage site, a first amplification oligonucleotide without a cleavage site, and a second amplification oligonucleotide with a cleavage site) and modified with a specific chemical group is loaded onto the surface of a chip processed with microreaction chambers and modified, so that most of the microreaction chambers of the chip have microspheres and no microspheres are present outside the microreaction chambers. Preferably, at most one microsphere is loaded into the microreaction chamber.

[0069] In some preferred embodiments, two amplification oligonucleotides are immobilized on the surface of the microspheres, including first amplification oligonucleotides all having cleavage sites and second amplification oligonucleotides all having cleavage sites, and the microspheres are modified with specific chemical groups, and the microspheres are loaded onto the surface of a chip processed with microreaction chambers and modified, so that most of the microreaction chambers of the chip have microspheres and no microspheres are outside the microreaction chambers. Preferably, at most one microsphere is loaded into the microreaction chamber.

[0070] According to a preferred embodiment, the microsphere surface has functional groups for fixing amplification oligonucleotides, including biotin, streptavidin, carboxyl, amino, silanol, azido, alkynyl, cycloalkynyl, ethylene oxide, etc., to carry out necessary primer connection. Such functional groups on the surface of the multiple amplification oligonucleotide carriers should have a certain density, for example, greater than 10,000 per microsphere.

[0071] According to a preferred embodiment, the surface of the microsphere should have functional groups that can reversibly bind to the surface of the microreaction chamber, including biotin, streptavidin, carboxyl, amino, silanol, azide, alkynyl, cycloalkynyl, ethylene oxide, etc. For example, the microsphere has biotin as a chemical group for immobilization, and the microreaction chamber of the gene sequencing chip has modified streptavidin, and the microsphere is connected to the microreaction chamber of the gene sequencing chip through the specific reaction of biotin and streptavidin; the microsphere has an amino group, which can react with the exposed thiol pre-connected in the microreaction chamber of the chip to immobilize the microsphere in the microreaction chamber.

[0072] The first step of amplification is to hybridize the amplification template polynucleotide to the carrier. The template polynucleotide is a double-stranded nucleic acid library or a single-stranded nucleic acid library before hybridization. Before hybridization, the double-stranded DNA needs to be unwound into a single strand and then complementary paired with the solid-phase amplification oligonucleotide. The single-stranded template polynucleotide contains a common adapter sequence at both ends, namely adapter sequence 1 and adapter sequence 2, wherein the adapter sequence 1 and the first amplification oligonucleotide are at least partially complementary paired; the adapter sequence 2 and the second amplification oligonucleotide are at least partially identical, so hybridization can be performed according to the principle of complementary base pairing. After the hybridization is completed, the excess template is washed away and enters the reaction solution containing DNA polymerase to react, so that the solid-phase primer will extend a complete complementary paired template chain according to the DNA template on the hybridization. Next, the unwinding solution is added to react and the unwinding DNA is washed away. In this way, there is no free nucleic acid library in the liquid phase inside the entire chip, and all template polynucleotides are copied to the surface of the solid-phase carrier.

[0073] According to a preferred embodiment, the amplification described in the present invention refers to amplification in the sense of this field. Amplification refers to gene amplification, which increases the number of copies of a gene through certain techniques. The amplification template described in the present invention contains common adapter sequences at both ends, which are called adapter sequence 1 and adapter sequence 2. For any amplification template, the same adapter sequence is connected at both ends. For example, two different adapter sequences are connected according to the difference between the 3' end and the 5' end. Of course, in the presence of complementary DNA chains, it can actually also contain a complementary adapter sequence of adapter sequence 1 and a complementary adapter sequence of adapter sequence 2. This all belongs to the common knowledge in this field.

[0074] In the present invention, at least part of the sequence of the adapter sequence 1 and the first amplification primer is complementary. In this way, when the amplification template is hybridized, hybridization can be carried out in the form of complementary pairing. At least part of the sequence of the adapter sequence 2 and the second amplification primer is the same. After the hybridization is completed, the reverse DNA strand of the amplification template is obtained by unwinding, or the complementary pairing strand is obtained. At this time, the adapter sequence is also reverse or complementary. Therefore, during the subsequent amplification reaction, the reverse adapter sequence needs to be combined with the second amplification primer. In other words, at least part of the sequence of the adapter sequence 2 and the second amplification primer is the same. Of course, the amplification primer generally needs to meet other requirements for connection to the carrier, such as containing a group connected to the carrier. The requirement of partial matching belongs to a common design method.

[0075] According to a preferred embodiment, when the template polynucleotide is hybridized to the medium surface, the conditions are controlled so that the ratio of the number of single-stranded template polynucleotide and microreaction chambers planted with amplification oligonucleotides or microspheres planted with amplification oligonucleotides is 1:1, so that most microreaction chambers only hybridize with one template sequence.

[0076] According to a preferred embodiment, after the template polynucleotide molecule to be tested is loaded onto the medium surface, an amplification reaction is performed so that the DNA template can be amplified on the surface, and the amplification is one of the amplification methods such as loop-mediated isothermal amplification (LAMP), recombinase polymerase amplification (RPA), recombinase-mediated isothermal nucleic acid amplification (RAA), nicking endonuclease constant temperature amplification (NEAR), rolling circle amplification (RCA), nucleic acid sequence-dependent amplification (NASBA), helicase-dependent amplification (HDA), strand displacement amplification (SDA), bridge amplification or PCR.

[0077] Constant temperature amplification technology is a new in vitro nucleic acid amplification technology developed after PCR technology. Compared with traditional PCR technology, constant temperature amplification has significant advantages: low detection line, no need for temperature change, fast amplification speed, and usually low reaction temperature, which reduces the requirement for high temperature resistance of the chip. Common constant temperature amplification technologies include: ① Nucleic acid sequence-based amplification technology (NASBA), which mainly relies on AMV reverse transcriptase, RNaseH and T7 RNA polymerase and two specially designed primers to complete constant temperature amplification; ② Rolling circle amplification technology (RCA), phi29DNA polymerase is an important component of the reaction, with continuous DNA synthesis ability and strand displacement activity; ③ Loop-mediated constant temperature amplification (LAMP), LAMP uses 4 or 6 primers, with strong specificity and high sensitivity; ④ Helicase amplification technology (HDA); ⑤ Recombinase polymerase amplification (RPA), RPA technology mainly relies on three enzymes: recombinase that can bind to single-stranded nucleic acids (oligonucleotide primers), single-stranded DNA binding protein (SSB) and strand displacement DNA polymerase. The mixture of these three enzymes is also active at room temperature, and the optimal reaction temperature is around 37°C; ⑥ Recombinase-mediated isothermal nucleic acid amplification technology (RAA), the technical principle is similar to RPA, the difference is that the recombinase of RAA comes from bacteria or fungi, while the recombinase of RPA comes from T4 phage; ⑦ Chain displacement amplification technology (SDA), its basic reaction system includes a restriction endonuclease, a DNA polymerase with chain displacement activity, two pairs of primers, dNTPs, as well as calcium, magnesium ions and a buffer system.

[0078] Loop-mediated isothermal nucleic acid amplification (LAMP) was first disclosed by Japanese scholar Notomi in 2000. It is a new technology that is used for isothermal amplification reactions at 60-65°C. Four (or six) specific primers are designed for the six regions of the target nucleic acid molecule, as well as a Bst DNA polymerase with strand displacement properties. The target sequence can be amplified efficiently, quickly, and highly specifically under isothermal conditions. The basic principle is that after the template DNA molecule is denatured, the inner and outer primers are extended under the action of Bst DNA polymerase, and then the outer primer is extended. At the same time, its extension product displaces the extension product of the inner primer to form a dumbbell-shaped DNA, and then enters the cyclic amplification stage, which is continuously extended and amplified, and finally forms a mixture of DNA fragments with stem-loop structure and polycyclic cauliflower-like structure.

[0079] Recombinase polymerase amplification (RPA) is a constant temperature amplification reaction at 37-42°C, which mainly relies on three enzymes: recombinase that can bind to single-stranded nucleic acids (such as amplification primers), single-stranded DNA binding proteins, and strand displacement DNA polymerases. The mixture of these three enzymes is also active at room temperature, and the optimal reaction temperature is around 37°C. Before binding to the complementary sequence, the primer will first bind to the recombinase to form a primer-recombinase fiber. During the reaction, the primer will open the double-stranded DNA as a template and exchange the strands under the action of the recombinase and its related coenzymes, and bind to the opened single strand at the complementary pairing. Next, the single-strand binding protein will bind to the opened single strand and maintain the single-stranded structure. Afterwards, the primer will unwind the double strand and synthesize a new strand under the action of the DNA polymerase with 5'-3' strand displacement activity, and finally form a new DNA double strand and the replaced DNA single strand. The primers at both ends undergo the above reaction under the action of the enzyme. The whole process is very fast and generally detectable amplification products can be obtained within ten minutes. Finally, the template can be amplified by 10 11 ~10 12 times.

[0080] The reactions of RAA and RPA are basically the same, except that the source of the recombinase is different. The recombinase of RPA comes from T4 phage, while the recombinase of RAA comes from bacteria or fungi.

[0081] There are many factors that affect the isothermal amplification technology, such as the design of primers. Different amplification technologies have different requirements for the number of primers. The isothermal amplification reaction involved in the present invention can use at least two forms of amplification oligonucleotides. For example, the amplification primers of RPA are different from conventional PCR primers. Generally, the length of its two primers is 20-45 nt. The amplification primer design of LAMP is more difficult and includes 4 or 6 primers. The specific design of the primers can be varied.

[0082] In the present invention, the amount of template polynucleotide in the amplification reaction can range from nanograms to micrograms.

[0083] According to a preferred embodiment, the amplification reaction solution includes a DNA polymerase and dNTPs, and the DNA polymerase can be a polymerase with strand displacement activity, such as Bst DNA polymerase, Sau DNA polymerase, phi29 DNA polymerase, etc. Because the efficiency of the polymerase for each base may be different, the concentration of dNTPs in the amplification reaction solution may be different. For nucleotide substrates with special modifications, the corresponding DNA polymerase should be able to recognize such nucleotide substrates. In some embodiments, the nucleotide substrates can be natural dNTPs; in other embodiments, the nucleotides can be modified using fluorescent groups, etc.

[0084] According to a preferred embodiment, the amplification reaction solution may also include a recombinase and a single-stranded binding protein. Exemplary recombinases include, for example, RecA protein, T4 uvsX recombinase, and homologous proteins or protein complexes such as SC-recA, BS-recA, Rad51, or their functional variants.

[0085] Before the sequencing reaction is carried out, the double-stranded amplification product needs to be linearized, that is, it needs to be turned into a single strand. The present invention adopts a shearing method. Specifically, among the three amplification oligonucleotides on the surface of the medium, there are a first amplification oligonucleotide without a shearing site, a first amplification oligonucleotide with a shearing site, and a second amplification oligonucleotide with a shearing site, and the aforementioned two shearing sites are different from each other; except for the different shearing sites, the other sequences of the two first amplification oligonucleotides are the same. After adding the first shearing liquid, the first amplification oligonucleotide with a shearing site can be acted on to specifically shear off the second strand, and the addition of the unwinding liquid reaction unwinds the sheared sequence, exposing a single strand (first strand) that can bind to the sequencing primer.

[0086] In some embodiments, two amplification oligonucleotides are connected to the surface of the medium, including a first amplification oligonucleotide with a cleavage site and a second amplification oligonucleotide with a cleavage site, and the two cleavage sites are different from each other; after the first shearing liquid is added, it acts on the first amplification oligonucleotide to specifically shear off the second chain, and the addition of a dewinding liquid to react dewinds the sheared sequence, thereby exposing a single chain (first chain) that can bind to a sequencing primer.

[0087] In addition, it is also necessary to reduce the possible noise signals generated by the sequencing reaction as much as possible. This goal is achieved through the end-capping reaction: adding end-capping liquid to the chip makes the 3' end of all solid-phase DNA blocked, so that it cannot be extended under the action of DNA polymerase to generate noise signals. After the above processing steps, the first-chain sequencing reaction can be carried out as long as the sequencing primer is hybridized.

[0088] In the present invention, the term "cleavage site" refers to a relatively broad meaning. Any cleavage method can be called a "cleavage site" as long as it can cut one chain of a double-stranded nucleic acid molecule at this site after acting on this site, so that only one polynucleotide chain remains on the surface of the solid phase medium, and the cleavage reaction cannot destroy the complementary hybridization between the remaining part of the cleaved single chain and the uncleaved single chain. The cleavage method includes, but is not limited to: photo-cleavage, suitable chemical cleavage, suitable enzymatic cleavage, ribonucleotide cleavage, abasic site cleavage, enzyme digestion with nicking endonuclease, hemimethylated DNA cleavage and the like.

[0089] Light Shearing

[0090] In the present invention, "photo-shearing" includes any method that utilizes light energy to shear a single strand in the nucleic acid to be tested. The aforementioned shearing site can be located in a non-nucleotide chemical spacer unit in the nucleic acid to be tested. The chemical spacer unit includes PC spacer phosphoramidite (4-(4,4'-dimethoxytrityl)butyrylamidemethyl)-1-(2-nitrophenyl)-ethyl]-2--cyanoethyl-(N,N-diisopropyl)-phosphoramidite, which can be purchased from Glen Research (Sterling, VA, USA), and the spacer unit can be cut by exposure to an ultraviolet light source. This spacer unit can be attached to the 5' end of the nucleotide single strand together with a thiophosphate group that allows attachment to a solid surface using standard techniques for chemical synthesis of oligonucleotides.

[0091] Chemical shearing

[0092] In the present invention, "chemical cleavage" includes any method that utilizes chemical reactions (including but not limited to redox reactions, hydrolysis reactions, enzymatic reactions, etc.) to promote / achieve cleavage of single-stranded polynucleotides. Generally, single-stranded polynucleotides may include one or more non-nucleotide chemical moieties and / or non-natural nucleotides and / or non-natural backbone connections to allow the chemical cleavage reaction to proceed.

[0093] Representatively, the chemical cleavage site can be a disulfide group, and a chemical reducing agent can be used, such as tris (2-carbonylethyl) phosphine hydrochloride (TCEP), mercaptoethanol, DTT, cysteine ​​and other substances to cut the disulfide bond. Representatively, the chemical cleavage site can be a peptide bond, and an enzyme that can promote the hydrolysis of peptide bonds, including proteinase K, is used to perform an enzymatic reaction to complete the cleavage reaction. Representatively, the chemical cleavage site can be a reducing cleavage type linking group, including but not limited to a unit containing an azo group or an azide group. For a chemical linking unit containing an azo group, the cleavage reaction can be completed by treating with a sodium dithionite solution. The residual end after cleavage is inert and no end-capping reaction is required, which is very convenient; for a chemical linking unit containing an azide group, TCEP or hydrazine can be used for treatment to complete the cleavage reaction. The unit containing an azo group or an azide group can be incorporated into the amplification oligonucleotide using standard methods for automated chemical DNA synthesis. Representatively, the chemical cleavage site can be an oxidative chemical linking group, including a diol linking unit, the number of which can be one or more; any substance that promotes diol cleavage can be used for cleavage, preferably periodate (e.g., sodium periodate aqueous solution) or potassium permanganate; after treatment with a cutting agent (e.g., periodate) to cut the diol, the cleavage product can be treated with a "capping agent" to neutralize the reactive species produced in the cleavage reaction. Suitable capping agents for this purpose include, but are not limited to, ethanolamine, triethylamine, triethanolamine, arginine, lysine, cysteamine, and the like. In a preferred embodiment, a capping agent (e.g., ethanolamine) can be mixed with a cutting agent (e.g., periodate) so that the reactive species is capped once formed. One or more diol linking units can be incorporated into the amplification oligonucleotide using standard methods for automated chemical DNA synthesis. Representatively, the chemical cleavage site can also be an acid-sensitive linking group, including, but not limited to, ketals, acetals, diphenylsiloxanes, carbonates, carbamates, and other connection methods. Any reaction substance or reaction system that promotes the hydrolysis of ketal, acetal, carbonate, carbamate or diphenylsiloxane can be used for shearing. The preferred reaction conditions are in an acidic buffer system with a pH of 2 to 3, at room temperature or 37°C, and the reaction time is 5 to 30 minutes to efficiently complete the cutting. The main product after cutting is a connecting unit with a hydroxyl group (or amino group, for carbamates) at each end, and the by-product is acetone (or other ketone substances), diphenylsilanol, carbon dioxide and other inert substances. The by-product will not participate in the subsequent DNA synthesis reaction and does not need to be removed in other steps.

[0094] Ribonucleotide cleavage

[0095] One or more ribonucleotides are incorporated into the amplification oligonucleotide, and then a suitable shearing agent including ribonuclease is used to selectively cut the phosphodiester bond between the deoxyribonucleotide and the ribonucleotide, thereby achieving the cutting of the nucleic acid molecule to be tested into a single-stranded sequencing template at a specific site. For example, the nucleotide single strand to be cut contains a ribonucleotide to provide a shearing site. The suitable shearing agent includes but is not limited to: metal ions, such as rare earth ions, which are also very effective, especially La3+, Tm3+, Yb3+, Lu3+ ions with high activity, or Fe(3) or Cu(3) or exposure to elevated pH, such as treatment with an alkali such as sodium hydroxide. It should be noted that the suitable shearing agent cannot cut the phosphodiester bond between two deoxyribonucleotides under the same conditions. The basic composition of the ribonucleotide is generally not important, but can be selected to optimize chemical (or enzymatic) cutting. For example, if cutting is to be performed by exposure to metal ions, especially rare earth metal ions, rUMP or rCMP is generally preferred. For cleavage with ribonucleases, preferably two or more consecutive ribonucleotides are included, for example 2 to 10 or 5 to 10 consecutive ribonucleotides. The exact sequence of ribonucleotides is generally not important, and suitable RNases include, for example, RNase A, which cuts after C and U residues. Therefore, when cleaved with RNase A, the cleavage site must contain at least one C or U ribonucleotide. Amplification oligonucleotides incorporating one or more ribonucleotides can be easily synthesized using standard techniques for chemical synthesis of oligonucleotides with suitable ribonucleotide precursors.

[0096] In the present invention, "abasic site" refers to a position in a nucleic acid molecule from which a base component has been removed. Abasic sites can exist naturally in DNA under physiological conditions by hydrolysis of nucleoside residues, and can also be formed chemically under artificial conditions (e.g., by the action of an enzyme). Once formed, the abasic site can be sheared using a suitable shearing method (e.g., by using an endonuclease or other single-stranded cutting enzyme, or by exposure to heat or alkali treatment), thereby providing a means for site-specific cutting of captured nucleic acids. It should be recognized by those of ordinary skill in the art that the use of heat or alkali may denature nucleic acid molecules and, therefore, may not be a preferred embodiment.

[0097] In a preferred embodiment, an abasic site can be generated at a predetermined position of an amplification oligonucleotide by first incorporating deoxyuridine (U) at a predetermined cleavage site for cleavage, and then uracil DNA glycosylase (UDG) can be used to remove the uracil base, thereby generating an abasic site at a specific position. The strand containing the abasic site can then be cleaved at the abasic site by treatment with an endonuclease (e.g., Endo IV endonuclease, AP lyase, FPG glycosylase / AP lyase, Endo VIII glycosylase / AP lyase), heat, or base. In addition to deoxyuridine, abasic sites can also be generated on non-natural / modified deoxyribonucleotides and cleaved in a similar manner by treatment with an endonuclease, heat, or base. For example, 8-oxoguanine can be converted to an abasic site by exposure to FPG glycosylase; deoxyinosine can be converted to an abasic site by exposure to AlkA glycosylase; and the resulting abasic site can then be cleaved by treatment with a suitable endonuclease (e.g., Endo IV, AP lyase). It should be noted that since the non-natural / modified nucleotides will be incorporated into the amplification oligonucleotide for the purpose of amplification, the non-natural / modified nucleotides in the present invention should be able to be used in the polymerase replication reaction of the amplification reaction. In a preferred embodiment, a suitable glycosylase and one or more suitable endonucleases can be mixed together for the shearing reaction. In such a mixture, the glycosylase and the endonuclease will generally be present in an activity ratio of at least about 2:1. In a specific embodiment, USER reagent available from New England Biolabs is used to form a single nucleotide nick at a uracil base in an amplification oligonucleotide, and treatment with an endonuclease generates a 3'-phosphate moiety at the cleavage site, which can be removed, if desired, by a suitable phosphatase (e.g., alkaline phosphatase).

[0098] Enzymatic digestion with nicking endonucleases

[0099] In the field of molecular biology, the use of nicking endonucleases to shear one strand of a double-stranded nucleic acid molecule is a commonly used technique. Nicking endonucleases are enzymes that selectively cleave one strand of a double-stranded nucleic acid and are well known in the field of molecular biology. The method can essentially use any nicking endonuclease, provided that the nicking site present on the amplification oligonucleotide contains a suitable recognition sequence.

[0100] Hemimethylated DNA cleavage

[0101] The hemimethylated DNA refers to an oligonucleotide containing one or more methylated nucleotides, which are opposite to the non-methylated deoxyribonucleotides on the complementary chain, so that the annealing of the two chains produces a hemimethylated duplex structure. For the shearing of the nucleic acid, site-specific cleavage can be achieved by cleaving with an endonuclease; the endonuclease is specific for the recognition sequence containing methylated nucleotides. Appropriate methylated nucleotide precursors can be used to prepare amplification oligonucleotides incorporating one or more methylated nucleotides using standard techniques for automated DNA synthesis.

[0102] In the present invention, after the cleavage reaction, the product of the cleavage reaction needs to be subjected to denaturation conditions to remove the cleaved strands that are not attached to the surface of the medium. For example, a formamide solution may be introduced to react and denature the nucleic acid.

[0103] According to a preferred embodiment, the two amplification oligonucleotides contain sites that can be cut, which means that the cutting sites on the two amplification oligonucleotides are different from each other, and the conditions for cutting are also different. In this way, when cutting, different cutting conditions are selected according to specific needs, and favorable cutting can be controlled. For example, cutting site 1 is uracil, and cutting site 2 is 8-oxoguanine; or, cutting site 1 is 8-oxoguanine, and cutting site 2 is uracil. Among them, the shearing of the amplified double-stranded template into a single strand refers to shearing the first amplification oligonucleotide or the second amplification oligonucleotide into two segments through the cutting site, and removing the single strand that is not connected to the solid phase medium. This process is also called "linearization".

[0104] According to a preferred embodiment, the linearized single-stranded nucleic acid is sequenced, and the sequencing is sequencing by synthesis or sequencing by ligation, preferably fluorescence sequencing. The sequencing principle of fluorescence sequencing is different from that of the sequencing methods of Illumina and the like. The principle of generating sequencing signals is that DNA polymerase binds the reaction substrate labeled with a fluorescent group on the 5' phosphate to the sequencing template according to the principle of base complementary pairing, and the released group will further decompose the fluorescent group under the action of alkaline phosphatase, so that when the DNA template is extended, the fluorescent group will be released and emit fluorescence under the excitation light of a specific wavelength, and this signal is collected. Due to the presence of alkaline phosphatase during sequencing, if the phosphate group is formed at the 3' end after the shearing reaction in step (5) and step (11), the phosphate group will be removed under the action of alkaline phosphatase and the extension reaction will continue, thereby generating a mixed signal, which seriously interferes with the subsequent sequencing analysis.

[0105] In order to overcome the above-mentioned defects, the technical solution of the present invention is to first remove the 3' terminal phosphate group, cap it and then perform first-strand sequencing. Specifically, when a phosphate group is formed at the 3' end after the shearing reaction, it is necessary to treat it with a phosphate kinase or phosphatase including T4 polynucleotide kinase to remove the 3' terminal phosphate group formed after shearing, and then cap this end.

[0106] End-capping is a common step in solid phase amplification. Common end-capping refers to the step of transferring 3'-end modified substrates such as ddNTPs to the 3' end of the nucleotide chain using a tool enzyme such as terminal transferase TdT, so that this end cannot continue to react, thereby reducing the occurrence of side reactions. The end-capping reaction is performed before the sequencing reaction.

[0107] For double-end sequencing, after the first strand sequencing reaction is completed, sufficient second strands for sequencing are required. The ingenuity of the present invention lies in that sufficient double-stranded amplicons are generated by one amplification, and the sufficient amount refers to sufficient for first strand sequencing and second strand sequencing reactions.

[0108] For an embodiment in which there are two types of amplification oligonucleotides on the surface of the medium, that is, both the first amplification oligonucleotide and the second amplification oligonucleotide contain a cleavage site, the 5' end of the sequencing primer in step (6) is modified with a specific group; the group is selected from one or more of amino, carboxyl, epoxy, hydroxyl, aldehyde, azido, alkynyl, cycloalkynyl, maleimide, succinimide, and thiol; the specific group can react with the group on the surface of the medium. Step (6) also includes, after the first chain sequencing reaction is completed, without unwinding, allowing the single-stranded polynucleotide extended from the sequencing primer to react with the group on the surface of the medium through the specific group at the 5' end of the sequencing primer, and fixed to the surface of the solid phase medium, the single-stranded polynucleotide is the second chain on the surface of the solid phase medium that is complementary to the first chain.

[0109] In order to reduce sequencing noise signals, end-capping is required before sequencing, that is, end-capping liquid is added to the chip so that the 3' ends of all solid phase DNA are capped. After the above processing steps, the second chain can be sequenced after hybridization with the sequencing primer.

[0110] In the present invention, it may be beneficial to add a cleaning solution for washing between each step of the amplification sequencing method. For example, after hybridization, a cleaning solution is added to wash away the excess template; after formamide unwinding, a cleaning solution is added to wash away the unwinding nucleotide single strands; after the shearing reaction or the end-capping reaction, the chip is cleaned, etc. Appropriate cleaning is very important to ensure the normal progress of the reaction.

[0111] In the present invention, the template polynucleotide refers to the nucleic acid fragment obtained by fragmenting the nucleic acid molecule to be tested and constructing a library, which can also be called an amplification template. The sequence of the template may be unknown. Before sequencing, the long nucleic acid molecule is broken into small fragments, and then connected to a specific linker sequence, and the amplification sequencing process can be performed. The fragmentation of the molecule to be tested can be performed using any of a variety of techniques known in the art, such as ultrasonic treatment, atomization, physical shearing, chemical cleavage or enzymatic hydrolysis. During the whole process, there is no restriction on the nucleic acid sequence fragment to be tested, and any sequence can be subjected to this operation. This is also the concept of complete sequencing. The size of the template polynucleotide is 50 to 10,000 bp, or 100 to 1,000 bp, and the longest template can be 10 kb, but the amplification effect is significantly affected at this time.

[0112] It should be noted that, generally, the template polynucleotide is in the form of a double-stranded molecule, and before hybridization, the double-stranded molecule needs to be unwound into a single-stranded molecule; specifically, the template polynucleotide can also be in the form of a single-stranded molecule and can be directly used for hybridization.

[0113] According to a preferred embodiment, the template polynucleotide includes a specific nucleotide sequence tag to indicate the source of the polynucleotide, specifically including a first index and a second index. In actual sequencing, in order to make full use of the sequencing throughput of a high-throughput sequencing chip, samples from multiple different sources are often sequenced on a chip. After sequencing is completed, it is necessary to distinguish the source of the sequence, which is done with the help of the nucleotide sequence tag (also called index). The sequencing method further includes sequencing the first index and the second index. The specific sequencing order is adjustable. For example, the first chain can be measured first, then the first index, then the second chain, and then the second index; or the first index can be measured first, then the first chain, then the second chain, and then the second index; or the first index can be measured first, then the first chain, then the second index, and then the second chain; or the first chain can be measured first, then the first index, then the second index, and then the second chain; or the first chain can be measured first, then the first index, then the second index, and then the second chain.

[0114] For gene sequencing methods, conventional methods, such as Illumina's sequencing methods, only measure one base per reaction. For the present invention, the number of bases per reaction is not the focus of the present invention. The double-end amplification sequencing method described in the present invention is more suitable for the 2+2 fluorescence switching sequencing previously disclosed by the applicant; however, conventional sequencing methods similar to Illumina types are not excluded. In particular, the content of patent CN201510815685.X can be incorporated into this patent by reference.

[0115] Example 1

[0116] 1. Load the microspheres modified with the solid-carrying group and two amplification primers into the micro-reaction chamber on the chip surface:

[0117] 1) Dilute the microsphere carrier to about 3M / μL with 1xPBS solution containing 0.01% Tween 20, and oscillate to mix.

[0118] 2) Inject 300 μL of the diluted microsphere solution into the chip injection port.

[0119] 3) Centrifuge the chip.

[0120] 2. Template pre-hybridization:

[0121] 1) According to the final template concentration added in the amplification reaction, continue to dilute the template and add an appropriate volume of 0.1MNaOH for unwinding. Use 1.5ml DNA Lobind EP tubes for template dilution and unwinding; if the diluted template does not need to be stored for a long time, it can be diluted with ultrapure water. If it needs to be stored for a long time, it can be diluted with TE. The following table shows the commonly used template concentrations and the volume of 0.1MNaOH added.

[0122] Final template concentration The volume of template and 0.1M NaOH added 1pM 4μL NaOH + 4μL 100pM template

[0123] 2) After adding 0.1 M NaOH, shake and mix, centrifuge quickly for 2 seconds, and let stand at room temperature for 5 minutes.

[0124] 3) After lysis, add 5x SSC solution according to the volume of the lysis solution to make the final volume of the solution 400 μL. Use a pipette to slowly pipette 10 times to mix and immediately place on ice for use. Remember not to oscillate to mix.

[0125] 4) Take the chip to be amplified and wash it with 500 μL seq buffer. If there are bubbles, add 200 μL IPA to drive out the bubbles and then wash it with 500 μL seq buffer.

[0126] 5) Take the template solution and add it to the chip. Add 200 μL of reaction solution to each chip. Use Kimtech to wipe the liquid at the entrance and exit of the chip, seal it with sealing film, put it into the flat-plate PCR instrument, and select the anneal program: 96℃, 30s; -0.05℃ / s;

[0127] 40℃, 10s; 25℃, forever.

[0128] 6) After the reaction is complete, take out the solution and place it on ice for later use.

[0129] 3. Initial extension reaction

[0130] 1) Take 400 μL of 2x phusion mixture and place it on ice, then add 400 μL of ultrapure water to dilute it by half, shake and mix, and place it on ice.

[0131] 2) Add the above mixed solution to the chip, add 400 μL to each chip, and place the chip on a flat-plate PCR instrument and heat at 72°C for 2 minutes.

[0132] 3) After the reaction is completed, add 400 μL of formamide into the chip, react at room temperature for 5 minutes, and then clean the chip with a cleaning solution.

[0133] 4. Recombinase polymerase amplification reaction

[0134] 1) Prepare the reaction solution according to the table below.

[0135] Reagents V / μL Hydration fluid 180 Magnesium acetate 15 Ultrapure water 105 Total volume 300

[0136] 2) After preparation, shake to mix and centrifuge quickly for 2 seconds.

[0137] 3) Clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of isopropanol to remove the bubbles and then clean it with 500 μL of cleaning solution.

[0138] 4) Add the prepared amplification reaction solution to the chip, place the chip on the PCR instrument, tighten the lid, and select the heating program: 40°C, 60 min; 4°C, forever.

[0139] 5. Shearing solution (USER enzyme mix) reaction, acting on shearing site 1

[0140] 1) Take 1.5 ml DNA Lobind EP tube and prepare the shearing reaction solution according to the table below.

[0141] Reagents V / μL USER enzyme 4 Cutsmart 40 Ultrapure water 356 Total 400

[0142] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0143] 3) After the amplification reaction, wash the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL IPA to drive out the bubbles and then wash with 500 μL of cleaning solution.

[0144] 4) Add the prepared shearing reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the shearing solution reaction program: 37°C, 30 min; 4°C, forever.

[0145] 6. Removal of Phospho-Terminus Reaction

[0146] 1) Take 1.5ml DNA Lobind EP tube and prepare the reaction solution according to the table below.

[0147] Reagents V / μL T4PNK enzyme 16 PNK buffer 40 Ultrapure water 344 Total 400

[0148] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0149] 3) After the shear reaction, clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL IPA to drive out the bubbles and then clean it with 500 μL of cleaning solution.

[0150] 4) Add the prepared mixed reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the reaction program: 37°C, 60 min; 4°C, forever.

[0151] 7. Unwinding

[0152] 1) After the reaction, clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then clean it with 500 μL of cleaning solution.

[0153] 2) Add 200 μL of formamide to each chip and react at room temperature (25°C) for 10 min.

[0154] 3) After the reaction is completed, add 1 ml of 1xTE for washing. If not sequenced immediately, seal with sealing film and store in a storage box in a 4°C refrigerator.

[0155] 8. Blocking solution (TdT enzyme mix) reaction

[0156] 1) Take 1.5mL DNA Lobind EP tube and prepare the end-capping reaction solution according to the table below.

[0157] Reagents V / μL TdT enzyme 4 10x buffer 40 <![CDATA[CoCl2]]> 40 ddNTP (10mM, each) 8 Ultrapure water 308 Total 400

[0158] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0159] 3) After the reaction, clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then clean it with 500 μL of cleaning solution.

[0160] 4) Add the prepared capping reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the capping solution reaction program: 37°C, 30 min; 4°C, forever.

[0161] 9. First-strand sequencing

[0162] 1) Dilute the sequencing primer dissolved in 1x TE to a concentration of 100 μM in an EP tube using hybridization solution to 2 μM.

[0163] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0164] 3) After the reaction, wash the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then wash with 500 μL of hybridization solution.

[0165] 4) Add the prepared mixed sequencing primer solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the sequencing primer hybridization program: 60°C, 7 min; 40°C, 3 min.

[0166] 5) After the reaction is completed, 500 μL of cleaning solution is added for cleaning, and then the first round of sequencing is performed.

[0167] 10. Shearing solution (Fpg enzyme mix) reaction, acting on shearing site 2

[0168] 1) Take 1.5mL DNA Lobind EP tube and prepare the shearing reaction solution according to the table below.

[0169] Reagents V / μL Fpg enzyme 10 10x NEB buffer 40 BSA 4 Ultrapure water 346 Total 400

[0170] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0171] 3) After sequencing, clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then clean it with 500 μL of cleaning solution.

[0172] 4) Add the prepared mixed reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the shearing solution reaction program: 37°C, 60 min; 4°C, forever.

[0173] 11. Removal of phosphate termini

[0174] 1) Take 1.5mL DNA Lobind EP tube and prepare the reaction solution according to the table below.

[0175] Reagents V / μL T4PNK enzyme 16 PNK buffer 40 Ultrapure water 344 Total 400

[0176] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0177] 3) After the shear reaction, clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL IPA to drive out the bubbles and then clean it with 500 μL of cleaning solution.

[0178] 4) Add the prepared mixed reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the reaction program: 37°C, 60 min; 4°C, forever.

[0179] 12. Recombinase polymerase amplification reaction

[0180] 1) Prepare the reaction solution according to the table below.

[0181]

[0182]

[0183] 2) After preparation, shake to mix and centrifuge quickly for 2 seconds.

[0184] 3) Clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of isopropanol to remove the bubbles and then clean it with 500 μL of cleaning solution.

[0185] 4) Add the prepared amplification reaction solution to the chip, place the chip on the PCR instrument, tighten the lid, and select the heating program: 40°C, 60 min; 4°C, forever.

[0186] 13. Shearing solution (sodium periodate) reaction, acting on the second amplification primer

[0187] 1) Take 1.5mL DNA Lobind EP tube and prepare the reaction solution according to the table below.

[0188] Reagents V / μL Sodium periodate 20 Phosphate buffer 40 Ultrapure water 340 Total 400

[0189] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0190] 3) Wash the amplified chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then wash with 500 μL of cleaning solution.

[0191] 4) Add the prepared mixed reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the shearing solution reaction program: 25°C, 30 min; 4°C, forever (protected from light).

[0192] 14. Unwind

[0193] 1) After the reaction, clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then clean it with 500 μL of cleaning solution.

[0194] 2) Add 200 μL of formamide to each chip and react at room temperature (25°C) for 10 min.

[0195] 3) After the reaction is completed, add 1 mL of 1xTE for washing. If not sequenced immediately, seal with sealing film and store in a storage box in a 4°C refrigerator.

[0196] 15. Blocking solution (TdT enzyme mix) reaction

[0197] 1) Take 1.5mL DNA Lobind EP tube and prepare the end-capping reaction solution according to the table below.

[0198] Reagents V / μL TdT enzyme 4 10x buffer 40 <![CDATA[CoCl2]]> 40 ddNTP (10mM, each) 8 Ultrapure water 308 Total 400

[0199] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0200] 3) After the reaction, clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then clean it with 500 μL of cleaning solution.

[0201] 4) Add the prepared capping reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the capping solution reaction program: 37°C, 30 min; 4°C, forever.

[0202] 16. Hybridization of the second sequencing primer

[0203] 1) Dilute the sequencing primer dissolved in 1x TE to a concentration of 100 μM in an EP tube using hybridization solution to 2 μM.

[0204] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0205] 3) After the reaction, wash the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then wash with 500 μL of hybridization solution.

[0206] 4) Add the prepared mixed sequencing primer solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the sequencing primer hybridization program: 60°C, 7 min; 40°C, 3 min.

[0207] 5) After the reaction is completed, 500 μL of cleaning solution is added for cleaning, and then a second round of sequencing is performed.

[0208] 17. Data Analysis

[0209] Second chain generation efficiency

[0210] Figure 1A The left image shows the brightness of the microspheres after the first strand is generated and hybridized with the fluorescently labeled probe. Figure 1A The right picture shows the brightness of the microspheres when the newly generated second-chain product hybridizes with the fluorescently labeled probe. Because the probes used in the first and second chains are labeled with the same fluorescent marker, the brightness of the microspheres can reflect the amount of the corresponding product. Figure 1B This is a second-strand generation efficiency diagram drawn using MATLAB software based on the brightness of the microspheres, where the X-axis is the brightness of the microspheres when hybridizing the first-strand fluorescent-labeled probe, and the Y-axis is the brightness of the microspheres when hybridizing the second-strand fluorescent-labeled probe. The slope of the scatter plot represents the second-strand generation efficiency. As can be seen from the figure, the second-strand generation efficiency is 78% of the first-strand, and the second-strand generation efficiency is relatively high, meeting the second-strand sequencing requirements.

[0211] Example 2

[0212] Steps 1-7 are the same as in Example 1, see above.

[0213] 8. Reaction with the end-capping solution (TdT enzyme mix) containing reversible terminal protection bases

[0214] 1) Take 1.5 ml DNA Lobind EP tube and prepare the end-capping reaction solution according to the table below.

[0215] Reagents V / ul TdT enzyme 4 10x buffer 40 <![CDATA[CoCl2]]> 40 Reversible dTTP 4 Ultrapure water 302 Stabilizer 10 Total 400

[0216] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0217] 3) After the RPA reaction, clean the chip with 500ul of cleaning solution. If there are bubbles, add 200ul of IPA to drive out the bubbles and then clean it with 500ul of cleaning solution.

[0218] 4) Add the prepared capping reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the capping solution reaction program: 37°C, 30 min; 4°C, forever.

[0219] 9. Hybridization Sequencing Primers

[0220] 1) Dilute the sequencing primer dissolved in 1x TE to a concentration of 100uM in an EP tube using hybridization solution to 2uM.

[0221] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0222] 3) After the unwinding reaction, wash the chip with 500ul of cleaning solution. If there are bubbles, add 200ul of IPA to drive out the bubbles and then wash with 500ul of hybridization solution.

[0223] 4) Add the prepared mixed sequencing primer solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the sequencing primer hybridization program: 60°C, 7 min; 40°C, 3 min.

[0224] 5) After the reaction is completed, add 500uL of washing solution for cleaning and then perform the first round of sequencing.

[0225] 10.TCEP deprotection reaction

[0226] 1) Take 1.5 ml DNA Lobind EP tube and prepare the deblocking reaction solution according to the table below.

[0227] Reagents V / ul TCEP 40 Tris base 40 NaCl 40 Sodium Ascorbate 20 10% Tween 20 2 Ultrapure water 258 Total 400

[0228] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0229] 3) After sequencing, clean the chip with 500ul of cleaning solution. If there are bubbles, add 200ul of IPA to drive out the bubbles and then clean it with 500ul of cleaning solution.

[0230] 4) Add the prepared mixed reaction solution to the chip, place the chip on the flat-plate PCR instrument, tighten the lid, and select the blocking solution reaction program: 65℃, 30min; 4℃, forever.

[0231] 11. Recombinase polymerase reaction

[0232] 1) Prepare the reaction solution according to the table below.

[0233] Reagents V / ul Hydration fluid 180 Magnesium acetate 15 Ultrapure water 95.25 Stabilizer 7.5 Total volume 300

[0234] 2) After preparation, shake to mix and centrifuge quickly for 2 seconds.

[0235] 3) Clean the chip with 500ul of cleaning solution. If there are bubbles, add 200ul of isopropanol to remove the bubbles and then clean it with 500ul of cleaning solution.

[0236] 4) Add the prepared amplification reaction solution to the chip, place the chip on the PCR instrument, tighten the lid, and select the heating program: 40°C, 60 min; 4°C, forever.

[0237] 12. Shearing solution (FPG enzyme mix) reaction

[0238] 1) Take 1.5 ml DNA Lobind EP tube and prepare the end-capping reaction solution according to the table below.

[0239] Reagents V / ul Fpg enzyme 10 10x NEBbuffer 40 BSA 4 Stabilizer 10 Ultrapure water 336 Total 400

[0240] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0241] 3) After sequencing, clean the chip with 500ul of cleaning solution. If there are bubbles, add 200ul of IPA to drive out the bubbles and then clean it with 500ul of cleaning solution.

[0242] 4) Add the prepared mixed reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the capping solution reaction program: 37°C, 60 min; 4°C, forever.

[0243] 13. Unwind

[0244] 1) After the end-capping solution reacts, clean the chip with 500ul of cleaning solution. If there are bubbles, add 200ul of IPA to drive out the bubbles and then clean it with 500ul of cleaning solution.

[0245] 2) Add 200ul of formamide to each chip and react at room temperature (25°C) for 10 minutes.

[0246] 3) After the reaction is completed, add 1 ml of 1xTE for washing. If not sequenced immediately, seal with sealing film and store in a storage box in a 4°C refrigerator.

[0247] 14. Blocking solution (TdT enzyme mix) reaction

[0248] 1) Take 1.5 ml DNA Lobind EP tube and prepare the end-capping reaction solution according to the table below.

[0249] Reagents V / ul TdT enzyme 4 10x buffer 40 CoCl2 40 ddNTP (10mM, each) 8 Ultrapure water 308 Total 400

[0250] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0251] 3) After the RPA reaction, clean the chip with 500ul of cleaning solution. If there are bubbles, add 200ul of IPA to drive out the bubbles and then clean it with 500ul of cleaning solution.

[0252] 4) Add the prepared capping reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the capping solution reaction program: 37°C, 30 min; 4°C, forever.

[0253] 15. Hybridization Sequencing Primers

[0254] 1) Dilute the sequencing primer dissolved in 1x TE to a concentration of 100uM in an EP tube using hybridization solution to 2uM.

[0255] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0256] 3) After the unwinding reaction, wash the chip with 500ul of cleaning solution. If there are bubbles, add 200ul of IPA to drive out the bubbles and then wash with 500ul of hybridization solution.

[0257] 4) Add the prepared mixed sequencing primer solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the sequencing primer hybridization program: 60°C, 7 min; 40°C, 3 min.

[0258] 5) After the reaction is completed, add 500uL of washing solution for cleaning and then perform the second round of sequencing.

[0259] 16. Data Analysis

[0260] Second chain generation efficiency

[0261] Figure 2A The left image shows the brightness of the microspheres after the first strand is generated and hybridized with the fluorescently labeled probe. Figure 2A The right picture shows the brightness of the microspheres when the newly generated second-chain product hybridizes with the fluorescently labeled probe. Because the probes used in the first and second chains are labeled with the same fluorescent marker, the brightness of the microspheres can reflect the amount of the corresponding product. Figure 2B This is a second-strand generation efficiency diagram drawn using MATLAB software based on the brightness of the microspheres, where the X-axis is the brightness of the microspheres when hybridizing the first-strand fluorescent-labeled probe, and the Y-axis is the brightness of the microspheres when hybridizing the second-strand fluorescent-labeled probe. The slope of the scatter plot represents the second-strand generation efficiency. As can be seen from the figure, the second-strand generation efficiency is 86% of the first-strand, and the second-strand generation efficiency is high, meeting the second-strand sequencing requirements.

[0262] Example 3

[0263] Steps 1-8 are the same as in Example 1, see above.

[0264] 9. First-strand sequencing

[0265] 1) Dilute the amplification primers dissolved in 1x TE to a concentration of 100 μM in an EP tube using hybridization buffer to 2 μM.

[0266] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0267] 3) After the end-capping reaction, wash the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then wash with 500 μL of hybridization solution.

[0268] 4) Add the prepared mixed amplification primer solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the sequencing primer hybridization program: 60°C, 7 min; 40°C, 3 min.

[0269] 5) After the reaction is completed, 500 μL of cleaning solution is added for cleaning, and then the first round of sequencing is performed.

[0270] 10. Solid phase ligation reaction

[0271] 1) Take 1.5 ml DNA Lobind EP tube and prepare solid phase ligation reaction solution according to the table below.

[0272] Reagents V / ul B3T 283 catalyst 17 Total 300

[0273] 2) After preparation, shake to mix and centrifuge quickly for 2 seconds.

[0274] 3) After sequencing, clean the chip with 500ul of cleaning solution. If there are bubbles, add 200ul of IPA to drive out the bubbles and then clean it with 500ul of cleaning solution.

[0275] 4) Add the prepared mixed reaction solution to the chip and place it at room temperature for 1 hour.

[0276] 11. Shearing solution (Fpg enzyme mix) reaction

[0277] 1) Take 1.5 ml DNA Lobind EP tube and prepare the shearing reaction solution according to the table below.

[0278] Reagents V / μL Fpg enzyme 10 10x NEB buffer 40 BSA 4 ultrapure water 346 Total 400

[0279] 2) Use 1ml of cleaning solution to clean the chip. If there are bubbles, use 1ml of IPA to remove them.

[0280] 3) Add the shearing reaction solution to the chip, seal it, place it on a flat-plate PCR instrument, and select the shearing program: 37°C,

[0281] 1h.

[0282] 4) After shearing, clean the chip with 1 ml of cleaning solution. If there are bubbles, use 1 ml of IPA to remove them.

[0283] 5) Add 1 ml of unwinding solution to the chip and place it at room temperature for 3 minutes to unwind.

[0284] 6) Add 1 ml of cleaning solution to clean the chip. If there are bubbles, use 1 ml of IPA to remove them.

[0285] 12. Phospholysis

[0286] 1) Prepare the phospholysis reaction solution in a 1.5 ml EP tube according to the following system.

[0287] Reagents V / ul T4PNK enzyme 16 10x NEB buffer 40 Ultrapure water 344 Total 400

[0288] 2) Use 1ml of cleaning solution to clean the chip. If there are bubbles, use 1ml of IPA to remove them.

[0289] 3) Add the phospholysis reaction solution to the chip, seal it, place it on a flat-plate PCR instrument, and select the shearing program: 37°C,

[0290] 1h.

[0291] 13. Capping reaction

[0292] 1) Take 1.5 ml DNA Lobind EP tube and prepare the end-capping reaction solution according to the table below.

[0293]

[0294]

[0295] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0296] 3) Clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then clean it with 500 μL of cleaning solution.

[0297] 4) Add the prepared capping reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the capping reaction program: 37°C, 30 min; 4°C, forever.

[0298] 14. Second Strand Sequencing

[0299] 1) Dilute the sequencing primer dissolved in 1x TE to a concentration of 100 μM in an EP tube using hybridization solution to 2 μM.

[0300] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0301] 3) After the reaction, wash the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then wash with 500 μL of hybridization solution.

[0302] 4) Add the prepared mixed sequencing primer solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the sequencing primer hybridization program: 60°C, 7 min; 40°C, 3 min.

[0303] 5) After the reaction is completed, add 500 μL of cleaning solution for cleaning, and then perform second-strand sequencing.

[0304] 15. Data Analysis

[0305] Second chain generation efficiency:

[0306] Figure 3A The left image shows the brightness of the microspheres after the first strand is generated and hybridized with the fluorescently labeled probe. Figure 3A The right picture shows the brightness of the microspheres when the newly generated second-chain product hybridizes with the fluorescently labeled probe. Because the probes used in the first and second chains are labeled with the same fluorescent marker, the brightness of the microspheres can reflect the amount of the corresponding product. Figure 3B This is a second-strand generation efficiency diagram drawn using MATLAB software based on the brightness of the microspheres, where the X-axis is the brightness of the microspheres when hybridizing the first-strand fluorescent-labeled probe, and the Y-axis is the brightness of the microspheres when hybridizing the second-strand fluorescent-labeled probe. The slope of the scatter plot represents the second-strand generation efficiency. It can be seen from the figure that the second-strand generation efficiency is 81% of the first-strand, and the second-strand generation efficiency is high, meeting the second-strand sequencing requirements.

[0307] Example 4

[0308] 1. Microsphere immobilization, wherein three amplification primers are connected to the surface of the microsphere: a first amplification primer with a cleavage site, a first amplification primer without a cleavage site, and a second amplification primer with a cleavage site;

[0309] 1) Dilute the microsphere carrier to about 3M / μL with 1xPBS solution containing 0.01% Tween 20, and oscillate to mix.

[0310] 2) Inject 300 μL of the diluted microsphere solution into the chip injection port.

[0311] 3) Centrifuge the chip.

[0312] 2. Template Prehybridization

[0313] 1) According to the final template concentration added in the amplification reaction, continue to dilute the template and add an appropriate volume of 0.1M NaOH for unwinding. Use 1.5ml DNA Lobind EP tubes for template dilution and unwinding; if the diluted template does not need to be stored for a long time, it can be diluted with ultrapure water. If it needs to be stored for a long time, it can be diluted with TE. The following table shows the commonly used template concentrations and the volume of 0.1M NaOH added.

[0314] Final template concentration The volume of template and 0.1M NaOH added 1pM 4μL 100pM template + 4μL NaOH

[0315] 2) After adding 0.1 M NaOH, shake and mix, centrifuge quickly for 2 seconds, and leave at room temperature for 5 minutes.

[0316] 3) After lysis, add 5x SSC solution according to the volume of the lysis solution to make the final volume of the solution 400 μL. Use a pipette to slowly pipette 10 times to mix and immediately place on ice for use. Remember not to oscillate to mix.

[0317] 4) Take the chip to be amplified and wash it with 500 μL seq buffer. If there are bubbles, add 200 μL IPA to drive out the bubbles and then wash it with 500 μL seq buffer.

[0318] 5) Take the template solution and add it to the chip. Add 200 μL of reaction solution to each chip. Use Kimtech to wipe the liquid at the entrance and exit of the chip, seal it with sealing film, put it into the flat-plate PCR instrument, and select the anneal program: 96℃, 30s; -0.05℃

[0319] / s; 40℃, 10s; 25℃, forever.

[0320] 6) After the reaction is complete, take out the solution and place it on ice for later use.

[0321] 3. Initial extension reaction

[0322] 1) Take 400 μL of 2x phusion mixture and place it on ice, then add 400 μL of ultrapure water to dilute it by half, shake and mix, and place it on ice.

[0323] 2) Add the above mixture to the chip, add 400 μL to each chip, and place the chip on a flat-plate PCR instrument at 72°C.

[0324] Heat for 2 minutes.

[0325] 3) After the reaction is completed, add 400 μL of formamide into the chip, react at room temperature for 5 minutes, and then clean the chip with a cleaning solution.

[0326] 4. Recombinase polymerase amplification reaction

[0327] 1) Prepare the reaction solution according to the table below.

[0328] Reagents V / μL Hydration fluid 180 Magnesium acetate 15 Ultrapure water 105 Total volume 300

[0329] 2) After preparation, shake to mix and centrifuge quickly for 2 seconds.

[0330] 3) Clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of isopropanol to remove the bubbles and then clean it with 500 μL of cleaning solution.

[0331] 4) Add the prepared amplification reaction solution to the chip, place the chip on the PCR instrument, tighten the lid, and select the heating program: 40°C, 60 min; 4°C, forever.

[0332] 5. Shearing solution (USER enzyme mix) reaction, shearing the first amplification primer

[0333] 1) Take 1.5 ml DNA Lobind EP tube and prepare the shearing reaction solution according to the table below.

[0334]

[0335]

[0336] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0337] 3) After the amplification reaction, wash the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL IPA to drive out the bubbles and then wash with 500 μL of cleaning solution.

[0338] 4) Add the prepared shearing reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the shearing reaction program: 37°C, 30 min; 4°C, forever.

[0339] 6. Unwind

[0340] 1) After the shearing liquid reaction, clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL IPA to drive out the bubbles and then clean it with 500 μL of cleaning solution.

[0341] 2) Add 200 μL of formamide to each chip and react at room temperature (25°C) for 10 min.

[0342] 3) After the reaction is completed, add 1 ml of 1xTE for washing. If not sequencing immediately, seal with sealing film and place at 4°C

[0343] Store in a storage box in the refrigerator.

[0344] 7. Blocking solution (TdT enzyme mix) reaction

[0345] 1) Take 1.5 ml DNA Lobind EP tube and prepare the end-capping reaction solution according to the table below.

[0346] Reagents V / μL TdT enzyme 4 10x buffer 40 <![CDATA[CoCl2]]> 40 dTTP 4 ultrapure water 312 Total 400

[0347] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0348] 3) Clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then clean it with 500 μL of cleaning solution.

[0349] 4) Add the prepared capping reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the capping reaction program: 37°C, 30 min; 4°C, forever.

[0350] 8. First-strand sequencing

[0351] 1) Dilute the sequencing primer dissolved in 1x TE to a concentration of 100 μM in an EP tube using hybridization solution to 2 μM.

[0352] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0353] 3) After the end-capping reaction, wash the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then wash with 500 μL of hybridization solution.

[0354] 4) Add the prepared mixed sequencing primer solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the sequencing primer hybridization program: 60°C, 7 min; 40°C, 3 min.

[0355] 5) After the reaction is completed, 500 μL of cleaning solution is added for cleaning, and then the first round of sequencing is performed.

[0356] 9. Shearing solution (Fpg enzyme mix) reaction, shearing the second amplification primer

[0357] 1) Take 1.5 ml DNA Lobind EP tube and prepare the shearing reaction solution according to the table below.

[0358] Reagents V / μL Fpg enzyme 10 10x NEB buffer 40 BSA 4 ultrapure water 346 Total 400

[0359] 2) Use 1ml of cleaning solution to clean the chip. If there are bubbles, use 1ml of IPA to remove them.

[0360] 3) Add the shearing reaction solution to the chip, seal it, place it on a flat-plate PCR instrument, and select the shearing program: 37°C,

[0361] 1h.

[0362] 4) After shearing, clean the chip with 1 ml of cleaning solution. If there are bubbles, use 1 ml of IPA to remove them.

[0363] 5) Add 1 ml of unwinding solution to the chip and place it at room temperature for 3 minutes to unwind.

[0364] 6) Add 1 ml of cleaning solution to clean the chip. If there are bubbles, use 1 ml of IPA to remove them.

[0365] 10. Phospholysis

[0366] 1) Prepare the phospholysis reaction solution in a 1.5 ml EP tube according to the following system.

[0367] Reagents V / ul T4PNK enzyme 16 10x NEB buffer 40 Ultrapure water 344 Total 400

[0368] 2) Use 1ml of cleaning solution to clean the chip. If there are bubbles, use 1ml of IPA to remove them.

[0369] 3) Add the phospholysis reaction solution to the chip, seal it, place it on a flat-plate PCR instrument, and select the shearing program: 37°C,

[0370] 1h.

[0371] 11. Capping reaction

[0372] 1) Take 1.5 ml DNA Lobind EP tube and prepare the end-capping reaction solution according to the table below.

[0373] Reagents V / μL TdT enzyme 4 10x buffer 40 <![CDATA[CoCl2]]> 40 dTTP 4 ultrapure water 312 Total 400

[0374] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0375] 3) Clean the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then clean it with 500 μL of cleaning solution.

[0376] 4) Add the prepared capping reaction solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the capping reaction program: 37°C, 30 min; 4°C, forever.

[0377] 12. Second Strand Sequencing

[0378] 1) Dilute the sequencing primer dissolved in 1x TE to a concentration of 100 μM in an EP tube using hybridization solution to 2 μM.

[0379] 2) After preparation, shake to mix, centrifuge quickly for 2 seconds, and place on ice for later use.

[0380] 3) After the reaction, wash the chip with 500 μL of cleaning solution. If there are bubbles, add 200 μL of IPA to drive out the bubbles and then wash with 500 μL of hybridization solution.

[0381] 4) Add the prepared mixed sequencing primer solution to the chip, place the chip on a flat-plate PCR instrument, tighten the lid, and select the sequencing primer hybridization program: 60°C, 7 min; 40°C, 3 min.

[0382] 5) After the reaction is completed, add 500 μL of cleaning solution for cleaning, and then perform second-strand sequencing.

[0383] 13. Data Analysis

[0384] Second chain generation efficiency

[0385] Figure 4A The left image shows the brightness of the microspheres after the first strand is generated and hybridized with the fluorescently labeled probe. Figure 4A The right picture shows the brightness of the microspheres when the newly generated second-chain product hybridizes with the fluorescently labeled probe. Because the probes used in the first and second chains are labeled with the same fluorescent marker, the brightness of the microspheres can reflect the amount of the corresponding product. Figure 4B This is a second-strand generation efficiency diagram drawn using MATLAB software based on the brightness of the microspheres, where the X-axis is the brightness of the microspheres when hybridizing the first-strand fluorescent-labeled probe, and the Y-axis is the brightness of the microspheres when hybridizing the second-strand fluorescent-labeled probe. The slope of the scatter plot represents the second-strand generation efficiency. It can be seen from the figure that the second-strand generation efficiency is 84% ​​of the first-strand, and the second-strand generation efficiency is relatively high, meeting the second-strand sequencing requirements.

[0386] The above are preferred implementation modes of the present invention. Those skilled in the art to which the present invention belongs can also change and modify the above implementation modes. Therefore, the present invention is not limited to the above specific implementation modes. Any obvious improvements, substitutions or modifications made by those skilled in the art on the basis of the present invention belong to the protection scope of the present invention.

Claims

1. A method for double-end amplification sequencing on a solid phase medium surface, characterized in that: include: (1) providing at least two amplification oligonucleotides fixed on the surface of a solid phase medium, that is, providing at least a first amplification oligonucleotide and a second amplification oligonucleotide; the at least two amplification oligonucleotides include a first amplification oligonucleotide having a cleavage site and a second amplification oligonucleotide having a cleavage site, and the two cleavage sites are different; the surface of the solid phase medium is modified with a chemical group; (2) providing a single-stranded template polynucleotide, and loading the single-stranded template polynucleotide onto the surface of a solid phase medium by hybridization with the first amplification oligonucleotide; the single-stranded template polynucleotide contains common linker sequences at both ends, namely, linker sequence 1 and linker sequence 2, wherein linker sequence 1 and at least a portion of the sequence of the first amplification oligonucleotide are complementary; and linker sequence 2 and at least a portion of the sequence of the second amplification oligonucleotide are identical; (3) initial extension: extending the first amplification oligonucleotide to generate an extension product complementary to the single-stranded template polynucleotide; (4) amplification: providing amplification reactants, performing amplification on the surface of the medium, and generating a plurality of double-stranded polynucleotides fixed on the surface of the medium, wherein the double-stranded polynucleotides include a first strand and a second strand; (5) Shearing: by acting on the first amplification oligonucleotide having a shearing site, the first amplification oligonucleotide is interrupted at the shearing site, and the second strand in the double-stranded polynucleotide is selectively removed; (6) Capping: adding a capping agent to block the 3' end of the polynucleotide chain or oligonucleotide on the surface of the medium; (7) First-strand sequencing: hybridization of the first sequencing primer and sequencing; A. The 5' end of the first sequencing primer is modified with a specific group; the group is selected from one or more of amino, carboxyl, epoxy, hydroxyl, aldehyde, azido, alkynyl, cycloalkynyl, maleimide, succinimide or thiol; the specific group can react with the chemical group modified on the surface of the solid phase medium; B. After the first-strand sequencing reaction is completed, the single-stranded polynucleotide extended from the first sequencing primer is reacted with the chemical group on the surface of the solid phase medium through the specific group at the 5' end of the first sequencing primer without unwinding, and is fixed to the surface of the solid phase medium. The single-stranded polynucleotide is the second strand on the surface of the solid phase medium that is complementary to the first strand; (8) Shearing: by acting on the second amplification oligonucleotide, breaking the second amplification oligonucleotide at the shearing site, and selectively removing the first strand of the double-stranded polynucleotide; (9) Capping: adding a capping agent to block the 3' end of the polynucleotide chain or oligonucleotide on the surface of the medium; (10) Second strand sequencing: hybridize the second sequencing primer and sequence.

2. The method according to claim 1, characterized in that The solid phase medium includes an inert substrate or matrix and a media material, wherein the media material is directly attached to the amplified oligonucleotide and is connected to the inert substrate or matrix by covalent or non-covalent forces; the media material includes but is not limited to a hydrogel layer, hydrogel microspheres, and magnetic microspheres; the material of the inert substrate or matrix includes but is not limited to glass, silicon, silicon dioxide, optical fiber or optical fiber bundle, resin, ceramic, metal, nitrocellulose, polyethylene, polystyrene, copolymers of styrene and other materials, polypropylene, acrylic acid, polybutylene or polyurethane.

3. The method according to claim 1, characterized in that The surface of the solid phase medium has discretely distributed concave structures, which are micro-reaction chambers for reactions to occur, and the shapes may be cylindrical, truncated cone, groove, quasi-truncated cone or quasi-hexagonal column structure, or a combination thereof.

4. The method according to claim 1, characterized in that: The chemical groups modified on the surface of the solid phase medium include at least one of amino, carboxyl, epoxy, hydroxyl, aldehyde, azido, alkynyl, cycloalkynyl, maleimide, succinimide or thiol; the at least two amplification oligonucleotides are fixed on the surface of the solid phase medium by reacting with the chemical groups.

5. The method according to claim 1, characterized in that The cleavage site allows for enzymatic, chemical or photochemical cleavage.

6. The method according to claim 5, characterized in that wherein said cleavage comprises contacting said solid phase medium with a composition comprising at least one enzyme to generate an abasic site at said cleavage site, wherein said cleavage occurs at said cleavage site.

7. The method according to claim 1, characterized in that After the cleavage reaction is completed, an extendable 3' end needs to be generated, that is, if a phosphate group is formed at the 3' end after the cleavage reaction, it is necessary to treat with a phosphate kinase or phosphatase including T4 polynucleotide kinase to remove the phosphate group at the 3' end formed after the cleavage to generate an extendable 3' end.

8. The method according to claim 1, characterized in that The amplification is one of loop-mediated isothermal amplification (LAMP), recombinase polymerase amplification (RPA), recombinase-mediated isothermal nucleic acid amplification (RAA), nicking endonuclease isothermal amplification (NEAR), rolling circle amplification (RCA), nucleic acid sequence-dependent amplification (NASBA), helicase-dependent amplification (HDA), strand displacement amplification (SDA) or bridge PCR.

9. The method according to claim 1, characterized in that: Wherein the template polynucleotide comprises a first index and a second index, and the method further comprises sequencing the first index and the second index.

10. The method according to any one of claims 1 to 9, characterized in that The sequencing is sequencing by synthesis or sequencing by ligation, preferably fluorescence sequencing.